Compare NGL & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NGL | HTFL |
|---|---|---|
| Founded | 1940 | 2007 |
| Country | United States | United States |
| Employees | 569 | 843 |
| Industry | Natural Gas Distribution | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | NGL | HTFL |
|---|---|---|
| Price | $16.31 | $25.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.20 |
| AVG Volume (30 Days) | 135.4K | ★ 1.2M |
| Earning Date | 05-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.66 |
| Revenue Next Year | N/A | $23.55 |
| P/E Ratio | $366.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.95 | $20.13 |
| 52 Week High | $18.80 | $41.22 |
| Indicator | NGL | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 42.97 |
| Support Level | $15.11 | $24.59 |
| Resistance Level | $16.45 | $32.69 |
| Average True Range (ATR) | 0.70 | 1.52 |
| MACD | 0.10 | 0.15 |
| Stochastic Oscillator | 98.35 | 30.40 |
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.